Genmab CEO won't rule out future factory on Danish soil: "But we are not at that point now"
Genmab’s plans for production on Danish soil fell through more than 20 years ago, but CEO Jan van de Winkel doesn’t rule out the possibility of it still happening one day.
Step by step over the past few years, Genmab has moved from being a lean biotech company with a single revenue stream to an established pharmaceutical company with several legs.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
